These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1283634)

  • 1. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
    Palomaki GE; Knight GJ; Haddow JE; Canick JA; Saller DN; Panizza DS
    Prenat Diagn; 1992 Nov; 12(11):925-30. PubMed ID: 1283634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
    Palomaki GE; Haddow JE; Knight GJ; Wald NJ; Kennard A; Canick JA; Saller DN; Blitzer MG; Dickerman LH; Fisher R
    Prenat Diagn; 1995 Aug; 15(8):713-23. PubMed ID: 7479589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.
    Goodburn SF; Yates JR; Raggatt PR; Carr C; Ferguson-Smith ME; Kershaw AJ; Milton PJ; Ferguson-Smith MA
    Prenat Diagn; 1994 May; 14(5):391-402. PubMed ID: 7521964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
    Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
    Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women.
    Kishida T; Hoshi N; Hattori R; Negishi H; Yamada H; Okuyama K; Hanatani K; Takagi T; Sagawa T; Fujimoto S
    Fetal Diagn Ther; 2000; 15(2):112-7. PubMed ID: 10720877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The advantages of using triple-marker screening for chromosomal abnormalities.
    Kellner LH; Weiss RR; Weiner Z; Neuer M; Martin GM; Schulman H; Lipper S
    Am J Obstet Gynecol; 1995 Mar; 172(3):831-6. PubMed ID: 7534448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
    Barkai G; Goldman B; Ries L; Chaki R; Zer T; Cuckle H
    Prenat Diagn; 1993 Sep; 13(9):843-50. PubMed ID: 7506408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
    Burton BK; Prins GS; Verp MS
    Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18.
    Leporrier N; Herrou M; Herlicoviez M; Leymarie P
    Br J Obstet Gynaecol; 1996 Apr; 103(4):335-8. PubMed ID: 8605130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of prenatal maternal serum screening for trisomy 18.
    Yankowitz J; Fulton A; Williamson R; Grant SS; Budelier WT
    Am J Obstet Gynecol; 1998 Mar; 178(3):446-50. PubMed ID: 9539506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths.
    Muller F; Aegerter P; Boue A
    Prenat Diagn; 1993 Jan; 13(1):29-43. PubMed ID: 8446569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome.
    Palomaki GE; Knight GJ; Haddow JE
    Prenat Diagn; 1994 Jan; 14(1):65-8. PubMed ID: 7514290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
    Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
    Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies.
    Greenberg F; Schmidt D; Darnule AT; Weyland BR; Rose E; Alpert E
    Am J Obstet Gynecol; 1992 May; 166(5):1388-92. PubMed ID: 1375811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities.
    Crandall BF; Hanson FW; Keener S; Matsumoto M; Miller W
    Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1864-7; discussion 1867-9. PubMed ID: 7686337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.